{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:41:18Z","timestamp":1792644078512,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025J01433"],"award-info":[{"award-number":["2025J01433"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119354","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:21:21Z","timestamp":1789971681000},"page":"119354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Small-molecule photosensitizer for enhanced antiangiogenesis and immunosuppressive tumor microenvironment reprogramming in anti-metastatic photodynamic therapy"],"prefix":"10.1016","volume":"320","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3196-9867","authenticated-orcid":false,"given":"Sijia","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9148-2206","authenticated-orcid":false,"given":"Juanjuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinluan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119354_bib1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41568-024-00708-4","article-title":"Why do patients with cancer die?","volume":"24","author":"Boire","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119354_bib2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","article-title":"Cancer metastases: challenges and opportunities","volume":"5","author":"Guan","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119354_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrclinonc.2011.156","article-title":"The value of progression-free survival to patients with advanced-stage cancer","volume":"9","author":"Fallowfield","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119354_bib4","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2503574122","article-title":"Dual-laser \u201c808 and 1,064 nm\u201d strategy that circumvents the Achilles' heel of photothermal therapy","volume":"122","author":"Ding","year":"2025","journal-title":"Pro. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.119354_bib5","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1007\/s40843-025-3937-7","article-title":"Bio-camouflaged nanoreactors with spatiotemporally controlled Cu2+-Fenton catalysis for enhanced starvation-augmented mild photothermal therapy","volume":"69","author":"Ding","year":"2026","journal-title":"Sci. China Mater."},{"key":"10.1016\/j.ejmech.2026.119354_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40364-025-00779-x","article-title":"Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies","volume":"13","author":"Liu","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ejmech.2026.119354_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102749","article-title":"Havoc in harmony: unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment","volume":"127","author":"Acharya","year":"2024","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ejmech.2026.119354_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119354_bib9","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1021\/acs.accounts.5c00488","article-title":"Precision phototherapy enabled by decoding complex microenvironments","volume":"58","author":"Ding","year":"2025","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119354_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","article-title":"Linking tumour angiogenesis and tumour immunity","volume":"26","author":"Kabir","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.119354_bib11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41577-025-01187-w","article-title":"Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy","volume":"25","author":"Lanitis","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.119354_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-021-00496-y","article-title":"Anti-angiogenic agents \u2014 overcoming tumour endothelial cell anergy and improving immunotherapy outcomes","volume":"18","author":"Huinen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119354_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41392-025-02140-y","article-title":"Phototherapy in cancer treatment: strategies and challenges","volume":"10","author":"Cai","year":"2025","journal-title":"Signal Transduct. Tar."},{"key":"10.1016\/j.ejmech.2026.119354_bib14","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.1039\/D5CS00599J","article-title":"Organic photosensitizers: from molecular design to phototheranostics","volume":"54","author":"Zhang","year":"2025","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2026.119354_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11426-025-2937-y","article-title":"Molecularly intelligent photosensitizers: pioneering a new era in photodynamic therapy","volume":"69","author":"Ding","year":"2026","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.ejmech.2026.119354_bib16","article-title":"Combretastatin A4-combined photodynamic therapy for enhanced tumor therapeutic efficacy","volume":"28","author":"Bao","year":"2021","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.ejmech.2026.119354_bib17","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1751-1097.2011.00943.x","article-title":"Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responses","volume":"87","author":"Marrero","year":"2011","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejmech.2026.119354_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1751-1097.2008.00395.x","article-title":"The vascular disrupting agent 5,6-Dimethylxanthenone-4-Acetic acid improves the antitumor efficacy and shortens treatment time associated with photochlor-sensitized photodynamic therapy in vivo","volume":"85","author":"Seshadri","year":"2009","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejmech.2026.119354_bib19","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1158\/1078-0432.CCR-04-2703","article-title":"Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-Dimethylxanthenone-4-Acetic acid: implications for combination therapy","volume":"11","author":"Seshadri","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119354_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2024.112476","article-title":"A dual-targeted small-molecule photosensitizer with enhanced dual antitumor and anti-vascular effect for metastatic advanced prostate cancer photodynamic therapy","volume":"232","author":"Chen","year":"2025","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.ejmech.2026.119354_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2017.05.023","article-title":"Advances in combination therapy of lung cancer: rationales, delivery technologies and dosage regimens","volume":"260","author":"Wu","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejmech.2026.119354_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt1851","article-title":"Machine learning-assisted exploration of multidrug-drug administration regimens for organoid arrays","volume":"11","author":"Yakavets","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119354_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1039\/D3BM01138K","article-title":"Covalent drugs based on small molecules and peptides for disease theranostics","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejmech.2026.119354_bib24","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1021\/acs.jmedchem.4c02661","article-title":"A medicinal chemistry perspective on FDA-approved small molecule drugs with a covalent mechanism of action","volume":"68","author":"Dalton","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119354_bib25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119354_bib26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1039\/C9CS00129H","article-title":"The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer","volume":"49","author":"Lo","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2026.119354_bib27","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1200\/JCO.2013.49.6968","article-title":"Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial","volume":"31","author":"Gilbert","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119354_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1215\/15228517-2008-078","article-title":"New (alternative) temozolomide regimens for the treatment of glioma","volume":"11","author":"Wick","year":"2009","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2026.119354_bib29","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/cncr.22239","article-title":"Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain","volume":"107","author":"Krown","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2026.119354_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0305-7372(97)90019-0","article-title":"Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials","volume":"23","author":"Newlands","year":"1997","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ejmech.2026.119354_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13046-015-0274-y","article-title":"Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro","volume":"35","author":"Sun","year":"2016","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2026.119354_bib32","first-page":"33","article-title":"Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas","volume":"16","author":"Kim","year":"2006","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2026.119354_bib33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/neuonc\/nos295","article-title":"Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma","volume":"15","author":"Omuro","year":"2013","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2026.119354_bib34","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.2080","article-title":"Sorafenib plus daily low dose temozolomide for relapsed glioblastoma: a phase II study","volume":"29","author":"Zustovich","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119354_bib35","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2010.28.15_suppl.2065","article-title":"Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)","volume":"28","author":"Khasraw","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119354_bib36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1369","article-title":"The anti-angiogenic basis of metronomic chemotherapy","volume":"4","author":"Kerbel","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119354_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/ijms19020255","article-title":"Solid lipid nanoparticles carrying temozolomide for Melanoma treatment. Preliminary in vitro and in vivo studies","volume":"19","author":"Clemente","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119354_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2023.05.012","article-title":"Temozolomide-fatty acid conjugates for glioblastoma multiforme: in vitro and in vivo evaluation","volume":"359","author":"Jatyan","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejmech.2026.119354_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2023.03.040","article-title":"Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma","volume":"357","author":"Janjua","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejmech.2026.119354_bib40","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jconrel.2022.08.024","article-title":"Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme","volume":"350","author":"Jatyan","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejmech.2026.119354_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114644","article-title":"A phthalocyanine-based photosensitizer for effectively combating triple negative breast cancer with enhanced photodynamic anticancer activity and immune response","volume":"241","author":"Huang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119354_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2021.109997","article-title":"A novel zinc phthalocyanine-indometacin photosensitizer with \u201cThree-in-one\u201d cyclooxygenase-2-driven dual targeting and aggregation inhibition for high-efficient anticancer therapy","volume":"198","author":"Huang","year":"2022","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.ejmech.2026.119354_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2022.110778","article-title":"A novel Pim-1 kinase-targeted photosensitizer to combat triple-negative breast cancer with enhanced photodynamic efficacy and reduced metastasis","volume":"207","author":"Huang","year":"2022","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.ejmech.2026.119354_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.111997","article-title":"A MCL-1-targeted photosensitizer to combat triple-negative breast cancer with enhanced photodynamic efficacy, sensitization to ROS-induced damage, and immune response","volume":"237","author":"Huang","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2026.119354_bib45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1351\/pac196511030371","article-title":"The exciton model in molecular spectroscopy","volume":"11","author":"Kasha","year":"1965","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ejmech.2026.119354_bib46","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/ange.201002307","article-title":"J-Aggregate: von ihrer zuf\u00e4lligen Entdeckung bis zum gezielten supramolekularen Aufbau funktioneller Farbstoffmaterialien","volume":"123","author":"W\u00fcrthner","year":"2011","journal-title":"Angew. Chem. Int. Edit."},{"key":"10.1016\/j.ejmech.2026.119354_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.168703","article-title":"Conformation-driven fluorocarbon-powered zinc(II) phthalocyanine for photodynamic therapy in hypoxic tumors via anti-aggregation, oxygen retention, and enhanced cellular uptake","volume":"523","author":"Gao","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejmech.2026.119354_bib48","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1021\/acs.jmedchem.0c01072","article-title":"Novel targeted photosensitizer as an immunomodulator for highly efficient therapy of T-Cell acute lymphoblastic leukemia","volume":"63","author":"Yuan","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119354_bib49","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1021\/acs.jmedchem.7b00682","article-title":"A molecular combination of Zinc(II) phthalocyanine and tamoxifen derivative for dual targeting photodynamic therapy and hormone therapy","volume":"60","author":"Zhang","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119354_bib50","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41467-020-15591-4","article-title":"An open source and reduce expenditure ROS generation strategy for chemodynamic\/photodynamic synergistic therapy","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119354_bib51","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1021\/acs.jmedchem.5c03494","article-title":"Reactive oxygen species detection with fluorescent probes: limitations and recommendations beyond DCFH-DA","volume":"69","author":"Karges","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119354_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2021.129878","article-title":"Improved detection of reactive oxygen species by DCFH-DA: new insight into self-amplification of fluorescence signal by light irradiation","volume":"339","author":"Yu","year":"2021","journal-title":"Sensors Actuat. B-Chem."},{"key":"10.1016\/j.ejmech.2026.119354_bib53","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119354_bib54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12964-022-00871-x","article-title":"Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts","volume":"20","author":"Mazurkiewicz","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2026.119354_bib55","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41419-019-2187-8","article-title":"TLR5: a prognostic and monitoring indicator for triple-negative breast cancer","volume":"10","author":"Shi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119354_bib56","doi-asserted-by":"crossref","first-page":"R217","DOI":"10.1016\/S1074-5521(99)80081-7","article-title":"Molecular angiogenesis","volume":"6","author":"Klagsbrun","year":"1999","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119354_bib57","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3760\/cma.j.issn.0366-6999.2010.06.017","article-title":"Expressions of SE-1, CD31 and CD105 in the vascular endothelial cells and serum of rat with hepatocellular carcinoma","volume":"123","author":"Wang","year":"2010","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ejmech.2026.119354_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/JCI193758","article-title":"Vessels encapsulating tumor clusters promote noninvasive metastasis of hepatocellular carcinoma by shaping an immunosuppressive microenvironment","volume":"136","author":"Huang","year":"2026","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.119354_bib59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molmed.2023.11.002","article-title":"Reprogramming endothelial cells to empower cancer immunotherapy","volume":"30","author":"Cleveland","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119354_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40364-021-00312-w","article-title":"Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment","volume":"9","author":"Chen","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ejmech.2026.119354_bib61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10456-026-10042-y","article-title":"An epigenetic switch in vascular phenotype augments anti-tumor immunity","volume":"29","author":"Kim","year":"2026","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejmech.2026.119354_bib62","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","article-title":"Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity","volume":"52","author":"Lee","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119354_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2026-015243","article-title":"IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2\/PD-1 therapy","volume":"14","author":"Geindreau","year":"2026","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejmech.2026.119354_bib64","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2020.07.022","article-title":"FoxP3+ T regulatory cells in cancer: prognostic biomarkers and therapeutic targets","volume":"490","author":"Saleh","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.119354_bib65","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1021\/acsnano.2c08834","article-title":"Spatial-drug-laden protease-activatable M1 macrophage system targets lung metastasis and potentiates antitumor immunity","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2026.119354_bib66","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","article-title":"Low-dose irradiation programs macrophage differentiation to an iNOS+\/M1 phenotype that orchestrates effective T cell immunotherapy","volume":"24","author":"Klug","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2026.119354_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009543","article-title":"Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8+CD69+ T cells","volume":"12","author":"Tang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejmech.2026.119354_bib68","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2019-128577","article-title":"Reprogramming leukemia cells into antigen presenting cells as a novel cancer vaccination immunotherapy","volume":"134","author":"Linde","year":"2019","journal-title":"Blood"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:20:04Z","timestamp":1792642804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":68,"alternative-id":["S0223523426007993"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119354","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small-molecule photosensitizer for enhanced antiangiogenesis and immunosuppressive tumor microenvironment reprogramming in anti-metastatic photodynamic therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119354"}}